180 related articles for article (PubMed ID: 13998657)
1. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
WALSHE JM
J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
[No Abstract] [Full Text] [Related]
2. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
[TBL] [Abstract][Full Text] [Related]
3. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
SCHEINBERG IH
Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
[No Abstract] [Full Text] [Related]
4. [Clinico-biological considerations on a case of Wilson's disease with normal ceruloplasmin levels].
REBUCCI GG; TASSINARI CA
Riv Patol Nerv Ment; 1962 Sep; 83():498-518. PubMed ID: 13973459
[No Abstract] [Full Text] [Related]
5. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
Gollan JL; Stocks J; Dormandy TL; Sherlock S
J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
SCHEINBERG IH; GITLIN D
Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
[No Abstract] [Full Text] [Related]
7. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
[No Abstract] [Full Text] [Related]
8. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
9. Observations on ceruloplasmin in Wilson's disease.
SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
[No Abstract] [Full Text] [Related]
10. Wilson's disease and the concentration of caeruloplasmin in serum.
SCHEINBERG IH; STERNLIEB I
Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
[No Abstract] [Full Text] [Related]
11. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
SCHEINBERG IH; MORELL AG
J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
[No Abstract] [Full Text] [Related]
12. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
[TBL] [Abstract][Full Text] [Related]
13. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
[No Abstract] [Full Text] [Related]
14. Ceruloplasmin in Wilson's disease.
Holtzman NA; Naughton MA; Iber FL; Gaumnitz BM
J Clin Invest; 1967 Jun; 46(6):993-1002. PubMed ID: 6026104
[TBL] [Abstract][Full Text] [Related]
15. [COPPER METABOLISM AND WILSON'S DISEASE].
LANGE J
Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
[No Abstract] [Full Text] [Related]
16. Metabolic aspects of Wilson's disease: a review.
SIMPSON JF
Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
[No Abstract] [Full Text] [Related]
17. Caeruloplasmin in Wilson's disease.
ROSENOER VM; FRANGLEN G
Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
[No Abstract] [Full Text] [Related]
18. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
HELLER GL
Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
[No Abstract] [Full Text] [Related]
19. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
20. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
